ChartRow logo
Share this page
BCRX
$7.79-2.87%
as of close, Oct 16, 2026
☾ AH $7.79 -2.87%
PeersMRNALLYMDTUNHJNJTMO

BioCryst Pharmaceuticals Inc. trailing returns

BioCryst Pharmaceuticals Inc.'s 10-year return is +6.8% a year (CAGR) (+92.8% cumulative). How BioCryst Pharmaceuticals Inc. (BCRX) has performed over the last day, week, month and year, over 5, 10, 20 and 30 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-2.9%+0.0%-2.9%—
5 days-8.9%+0.0%-8.9%-8.9%Oct 16
1 month-7.6%+0.0%-7.6%-11.3%Oct 16
YTD-0.1%+0.0%-0.1%-29.9%Oct 16
1 year+15.9%+0.0%+15.9%-29.9%Oct 2026
5 years-12.4%+0.0%-12.4%-48.5%-79.1%Apr 2024
10 years+6.8%+0.0%+6.8%+92.8%-83.6%Nov 2019
20 years-2.1%+0.0%-2.1%-34.8%-93.1%Nov 2008
30 years-1.3%+0.0%-1.3%-32.3%-97.7%Jul 2002
Since inception (1994)+0.6%+0.0%+0.6%+19.8%-97.7%Jul 2002

Growth of BCRX#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years-12.4%/year · -48.5%
  • 10 years+6.8%/year · +92.8%
  • 20 years-2.1%/year · -34.8%
  • 30 years-1.3%/year · -32.3%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in BCRX's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is BioCryst Pharmaceuticals Inc.'s 10-year return?
Over the last 10 years, BioCryst Pharmaceuticals Inc. (BCRX) returned about +6.8% a year annualized (+92.8% cumulative total return).
What is BioCryst Pharmaceuticals Inc.'s 20-year annualized return?
Over the last 20 years, BioCryst Pharmaceuticals Inc. (BCRX) compounded at about -2.1% a year (-34.8% cumulative).
What is BioCryst Pharmaceuticals Inc.'s 30-year annualized return?
Over the last 30 years, BioCryst Pharmaceuticals Inc. (BCRX) compounded at about -1.3% a year (-32.3% cumulative).
What is BioCryst Pharmaceuticals Inc.'s return since inception?
Since 1994, BioCryst Pharmaceuticals Inc. (BCRX) has compounded at about +0.6% a year — +19.8% in total.

More on BioCryst Pharmaceuticals Inc.